Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive rats

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2468-2476

  Dai, Yi ^a,b   Weinreb, Robert N ^a   Kim, Keun Young ^c   Nguyen, Duy ^a   Park, Sangwoo ^a   Sun, Xinghuai ^b   Lindsey, James D ^a   Ellisman, Mark H ^c   Ju, Won Kyu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; MITOCHONDRIAL PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPA1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL LABELING; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GLAUCOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAOCULAR HYPERTENSION; LASER COAGULATION; MITOCHONDRION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA CELL; RETINA GANGLION CELL; RETINA INJURY; SPRAGUE DAWLEY RAT; TRABECULAR MESHWORK; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GTP PHOSPHOHYDROLASES; GUANIDINES; INJECTIONS, INTRAPERITONEAL; INTRAOCULAR PRESSURE; MITOCHONDRIA; NEUROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OCULAR HYPERTENSION; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79956007488     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5873     Document Type: Article

References (41)

1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
2. Ju WK, Kim KY, Lindsey JD, et al. Intraocular pressure elevation induces mitochondrial fission and triggers OPA1 release in glaucomatous optic nerve. Invest Ophthalmol Vis Sci. 2008;49:4903-4911.
3. Ju WK, Kim KY, Angert M, et al. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci. 2009;50: 707-716.
4. Barsoum MJ, Yuan H, Gerencser AA, et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006;25:3900-3911.
5. Yuan H, Gerencser AA, Liot G, et al. Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons. Cell Death Differ. 2007;14:462-471.
6. Westermann B. Nitric oxide links mitochondrial fission to Alzheimer's disease. Sci Signal. 2009;2:pe29.
7. Cho DH, Nakamura T, Fang J, et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science. 2009;324:102-105.
8. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999;96:9944-9948.
9. Neufeld AH. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull. 2004;62:455-459.
10. Pang IH, Johnson EC, Jia L, et al. Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressureinduced optic nerve damage. Invest Ophthalmol Vis Sci. 2005;46: 1313-1321.
11. Libby RT, Howell GR, Pang IH, et al. Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model. BMC Neurosci. 2007;8:108.
12. Cipolat S, Rudka T, Hartmann D, et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell. 2006;126:163-175.
13. Ishihara N, Fujita Y, Oka T, Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006; 25:2966-2977.
14. Ju WK, Misaka T, Kushnareva Y, et al. OPA1 expression in the normal rat retina and optic nerve. J Comp Neurol. 2005;488:1-10.
15. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002;43:402-410.
16. Pease ME, Zack DJ, Berlinicke C, et al. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci. 2009;50:2194-2200.
17. Bostanci MO, Bagirici F. Neuroprotective effect of aminoguanidine on iron-induced neurotoxicity. Brain Res Bull. 2008;76:57-62.
18. Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol. 1995;268:R286-R292.
19. Chow SK, Hakozaki H, Price DL, et al. Automated microscopy system for mosaic acquisition and processing. J Microsc. 2006;222: 76-84.
20. Price DL, Chow SK, Maclean NA, et al. High-resolution large-scale mosaic imaging using multiphoton microscopy to characterize transgenic mouse models of human neurological disorders. Neuroinformatics. 2006;4:65-80.
21. Bossy-Wetzel E, Talantova MV, Lee WD, et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron. 2004;41:351-365.
22. Nakamura T, Lipton SA. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis. 2010;15:1354-1363.
23. Ju WK, Kim KY, Park SJ, et al. Nitric oxide is involved in sustained and delayed cell death of rat retina following transient ischemia. Brain Res. 2000;881:231-236.
24. Geyer O, Almog J, Lupu-Meiri M, Lazar M, Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 1995;374:399-402.
25. Yucel I, Akar Y, Yucel G, Ciftcioglu MA, Keles N, Aslan M. Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vision Res. 2005;45:1107-1114.
26. Polak K, Luksch A, Berisha F, Fuchsjaeger-Mayrl G, Dallinger S, Schmetterer L. Altered nitric oxide system in patients with openangle glaucoma. Arch Ophthalmol. 2007;125:494-498.
27. Park SH, Kim JH, Kim YH, Park CK. Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma. Vision Res. 2007;47:2732-2740.
28. Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic Biol Med. 2008;45:367-376.
29. Tezel G, Chauhan BC, LeBlanc RP, Wax MB. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Invest Ophthalmol Vis Sci. 2003;44:3025-3033.
30. Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol. 2004;107:352-358.
31. Schmidt JF, Agapova OA, Yang P, Kaufman PL, Hernandez MR. Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy. Br J Ophthalmol. 2007;91:1219-1224.
32. Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1437-1446.
33. Ergorul C, Ray A, Huang W, et al. Hypoxia inducible factor-1alpha (HIF-1alpha) and some HIF-1 target genes are elevated in experimental glaucoma. J Mol Neurosci. 2010;42:183-191.
34. Jacquemin E, de Kozak Y, Thillaye B, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest Ophthalmol Vis Sci. 1996; 37:1187-1196.
35. Koeberle PD, Ball AK. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Exp Neurol. 1999;158:366-381.
36. Kobayashi M, Kuroiwa T, Shimokawa R, Okeda R, Tokoro T. Nitric oxide synthase expression in ischemic rat retinas. Jpn J Ophthalmol. 2000;44:235-244.
37. Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye (Lond). 2004;18:306-313.
38. Walker RJ, Steinle JJ. Role of beta-adrenergic receptors in inflammatory marker expression in Muller cells. Invest Ophthalmol Vis Sci. 2007;48:5276-5281.
39. Kaur C, Sivakumar V, Foulds WS, Luu CD, Ling EA. Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia. Invest Ophthalmol Vis Sci. 2009;50:5364-5374.
40. Tezel G, Luo C, Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci. 2007;48:1201-1211.
41. Ju WK, Kim KY, Duong-Polk KX, Lindsey JD, Ellisman MH, Weinreb RN. Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma. Mol Vis. 2010;16: 1331-1342.